CPIX - Rasio utang marang kapitalisasi buku Cumberland Pharmaceuticals Inc

The historical debt-to-book capitalization trend demonstrates the evolution of the credit load for Cumberland Pharmaceuticals (CPIX) amid the saturation of the US antidote market. The value 0.28 reflects the most recent metric reading. The financial model relies on sales of the hospital drugs Acetadote and Caldolor. Ownership of niche emergency care products provides the company with high resilience to market shocks.

Analyzing the debt load of Cumberland Pharmaceuticals (CPIX) relative to its balance sheet capital allows for an assessment of the company's financial stability. This ratio compares the issuer's total liabilities to its net assets. An increase in this metric signals insolvency risks, whereas a minimum value may indicate an inefficient use of leverage. Stable demand for hospital drugs ensures a predictable cash flow, enabling Cumberland Pharmaceuticals (CPIX) to safely service its debt while maintaining high profitability.